-
Study aim
-
This study aims to assess the effect of ESWT as an adjunct therapy in chronic wound treatment.
-
Design
-
A parallel randomized clinical trial, 50 participants (25 each group), double-blind,
-
Settings and conduct
-
Fifty patients with chronic venous wounds are randomly divided into two groups of ESWT and control using random allocation software. ESWT is applied weekly along with routine compression bandaging for four weeks. The Control group receives sham ESWT along with compression bandaging. the pain score, wound size, secretion rate, patient’s satisfaction and quality of life are assessed at baseline, week 4, and week 8. The study is multi-centered and is carried out in Alzahra, Amin, and Kashani Hospitals.
To blind the study, the shockwave machine is used in the control group as well, but it is off. Also, in the follow-ups, patients are assessed by a doctor who is blinded to the participants' groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: older than 18 years old, the presence of leg ulceration due to underlying venous insufficiency, ulcer size of greater than 1 cm2, ulcer must have persisted for at least 6 weeks.
Exclusion criteria: the history of venous surgery in the last 6 months, known rheumatoid arthritis or systemic vasculitis, acute deep vein thrombosis, coagulopathies, tumors, diabetes, cardiovascular diseases, kidney diseases, pregnancy, having conditions unable to tolerate ESWT such as severe arterial hypertension, anticoagulant therapy, wound infection during the treatment, and resulting in antibiotic regimen, or change of treatment during the study.
-
Intervention groups
-
Intervention group: Extracorporeal shockwave therapy (ESWT) along with compression bandaging.
Control group: Sham ESWT along with compression bandaging.
-
Main outcome variables
-
Wound size; secretion rate; patients’ satisfaction; quality of life; and pain intensity